ART5537
Based on 1 Customer Validation
ART5537 is a selective EXO1 inhibitor with a IC50 of 3.4 nM and a Kd of 6.8 nM. ART5537 exerts cellular homologous recombination (HR) inhibition with EC50 of 7.2 nM in HAP1 parental cells. ART5537 shows >200-fold selectivity over a panel of the wider nuclease superfamily. ART5537 exerts biological effects that are exclusively driven by EXO1 inhibition. ART5537 demonstrates sensitization to ionizing radiation and synergy with Olaparib (HY-10162). ART5537 can be used for research in breast cancer and colorectal adenocarcinoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.84%
- Formule: C23H18ClN5O3
- Masse moléculaire:447.87
-
Stockage:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
-
Solvant et solubilité
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
ART5537 (0.0001-10 μM) displays unambiguous dose-dependent cellular target engagement with an EC50 = 55 nM[1].
ART5537 (0.001-10 μM) has no activation HAP1 EXO1 KO cells, shows no further effect over KO of EXO1 (∼ 50% reduction) and induces a dose-dependent retention of GPF2-EXO1 on chromatin in a U-2 OS Flp-In line [1].
ART5537 (7 days) is not a broadly cytotoxic and has a mild EXO1-dependent sensitivity in MDA-MB-436 (EC50 = 4.0 nM), HCC 1937 (EC50 = 5.3 nM), SUM 149PT (EC50 = 5.0 nM) and HCC38 (EC50 = 8.3 nM) cells[1].
ART5537 (5 days) exhibits no ubiquitous cytotoxicity in HCT116 cells following cotreatment with Olaparib (HY-10162) [1].
ART5537 (7 days) combined with Olaparib exerts a strong synergistic effect in radiation-treated wild-type HCT116 cells, but no such effect is observed in the two radiation-treated EXO1 knockout clones[1].
ART5537 (0.01-100 μM, 6 days) effectively inhibits EXO1, and when combined with Olaparib in radiation-treated HCT116 cells, it significantly enhances the cancer cell-killing effect and greatly increases the activity potency[1].
ART5537 inhibits EXO1 in HCT116 cells and results in a > 40-fold sensitization, has suitable physicochemical properties for use as a cell probe with high thermodynamic solubility and good passive permeability and is unstable in human and mouse liver microsomes[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT116 cells
-
Concentration:0.01, 0.1, 10 and 100 μM
-
Incubation Time:6 days
-
Result:Resulted a > 40-fold sensitization.
Potently sensitized cells irradiated with 3 × 1 Gy (EC50 = 144 nM).
| Species | Dose | Route | CL_obs | T1/2 | Vss |
|---|---|---|---|---|---|
| Mice[1] | 0.2 mg/kg | i.v. | 111 mL/min/kg | 0.7 h | 5.7 L/kg |
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Appearance Solid
-
Masse moléculaire 447.87
-
Formule C23H18ClN5O3
-
Color White to off-white
-
SMILES
C[C@@H](C1=CC=CC=C1)N2CN(C3=NC=C(Cl)C4=C3C=NC=C4)N5C=CC(C(O)=C5C2=O)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvant et solubilité
DMSO : 50 mg/mL (111.64 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Pureté et documentation
-
Fiche technique (280 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.2328 mL | 11.1640 mL | 22.3279 mL | 55.8198 mL |
| 5 mM | 0.4466 mL | 2.2328 mL | 4.4656 mL | 11.1640 mL | |
| 10 mM | 0.2233 mL | 1.1164 mL | 2.2328 mL | 5.5820 mL | |
| 15 mM | 0.1489 mL | 0.7443 mL | 1.4885 mL | 3.7213 mL | |
| 20 mM | 0.1116 mL | 0.5582 mL | 1.1164 mL | 2.7910 mL | |
| 25 mM | 0.0893 mL | 0.4466 mL | 0.8931 mL | 2.2328 mL | |
| 30 mM | 0.0744 mL | 0.3721 mL | 0.7443 mL | 1.8607 mL | |
| 40 mM | 0.0558 mL | 0.2791 mL | 0.5582 mL | 1.3955 mL | |
| 50 mM | 0.0447 mL | 0.2233 mL | 0.4466 mL | 1.1164 mL | |
| 60 mM | 0.0372 mL | 0.1861 mL | 0.3721 mL | 0.9303 mL | |
| 80 mM | 0.0279 mL | 0.1395 mL | 0.2791 mL | 0.6977 mL | |
| 100 mM | 0.0223 mL | 0.1116 mL | 0.2233 mL | 0.5582 mL |
ART5537 Related Classifications
HY-180573 Related Classifications
Powered by Bioz